Psychiatric uses of beta-blockers.

H Cuche, P Deniker
{"title":"Psychiatric uses of beta-blockers.","authors":"H Cuche,&nbsp;P Deniker","doi":"10.1055/s-2007-1019644","DOIUrl":null,"url":null,"abstract":"<p><p>Beta-blocking agents have been used for many years in psychiatry. But many are suspicious about their mechanisms and therapeutic effects. In this review, the most part of clinical trials is reported and criticized. With the exception of anxiolytic effects, the other therapeutic effects are still questionable for many reasons, such as the methodology of clinical trials. In this paper, others agents which interact with the noradrenergic system are envisaged. It is taking into account all these factors (alpha and beta receptors, alpha and beta agents) that we can looking for award for a real progress in the field of biochemical psychiatry.</p>","PeriodicalId":76325,"journal":{"name":"Pharmakopsychiatrie, Neuro-Psychopharmakologie","volume":"13 5","pages":"267-72"},"PeriodicalIF":0.0000,"publicationDate":"1980-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2007-1019644","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmakopsychiatrie, Neuro-Psychopharmakologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-2007-1019644","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Beta-blocking agents have been used for many years in psychiatry. But many are suspicious about their mechanisms and therapeutic effects. In this review, the most part of clinical trials is reported and criticized. With the exception of anxiolytic effects, the other therapeutic effects are still questionable for many reasons, such as the methodology of clinical trials. In this paper, others agents which interact with the noradrenergic system are envisaged. It is taking into account all these factors (alpha and beta receptors, alpha and beta agents) that we can looking for award for a real progress in the field of biochemical psychiatry.

-受体阻滞剂的精神病学应用。
-阻滞剂已在精神病学中使用多年。但许多人对其机制和治疗效果持怀疑态度。在这篇综述中,对大部分临床试验进行了报道和批评。除抗焦虑作用外,由于临床试验的方法学等原因,其他治疗效果仍值得商榷。本文展望了与去甲肾上腺素能系统相互作用的其他药物。考虑到所有这些因素(α和β受体,α和β因子),我们才能在生化精神病学领域寻找真正的进步。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信